A Randomised, Placebo-controlled, Double-blind, Parallel Groups, Multinational, Multicentre Trial Assessing the Effect of Barusiban Administered Subcutaneously on the Day of Transfer on Implantation and Pregnancy Rates in IVF/ICSI Patients
Phase of Trial: Phase II
Latest Information Update: 24 Aug 2015
At a glance
- Drugs Barusiban (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- Acronyms BASIC
- Sponsors Ferring Pharmaceuticals
- 15 Jun 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record..
- 23 Apr 2015 Planned End Date changed from 1 Apr 2015 to 1 Jun 2015, as reported by ClinicalTrials.gov.
- 25 Nov 2014 Planned End Date changed from 1 Nov 2014 to 1 Apr 2015, according to the ClinicalTrials.gov record.